Prelude Therapeutics, Inc. (PRLD)
3.40
+0.14
(+4.29%)
USD |
NASDAQ |
Oct 19, 16:00
3.40
0.00 (0.00%)
After-Hours: 16:13
Prelude Therapeutics Cash from Operations (Annual) : -56.30M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -56.30M |
| December 31, 2024 | -102.89M |
| December 31, 2023 | -107.06M |
| December 31, 2022 | -83.73M |
| Date | Value |
|---|---|
| December 31, 2021 | -83.53M |
| December 31, 2020 | -46.18M |
| December 31, 2019 | -25.66M |
| December 31, 2018 | -12.95M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Q32 Bio, Inc. | -33.54M |
| Intellia Therapeutics, Inc. | -394.74M |
| Twist Bioscience Corp. | -47.63M |
| Beam Therapeutics, Inc. | -345.10M |
| Revolution Medicines, Inc. | -897.74M |